Ryman Healthcare Limited
RYHTY
$7.45
-$0.04-0.53%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.40% | 5.92% | 11.93% | 15.00% | 15.62% |
| Total Other Revenue | 43.89% | 39.31% | 77.31% | 82.18% | 292.22% |
| Total Revenue | 11.03% | 7.50% | 15.66% | 18.83% | 19.60% |
| Cost of Revenue | 18.93% | 15.15% | 26.09% | 29.55% | 7.95% |
| Gross Profit | -43.73% | -45.52% | -78.34% | -77.74% | 373.48% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 18.25% | 14.49% | 16.41% | 19.60% | -6.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.89% | 15.11% | 25.60% | 29.05% | 6.76% |
| Operating Income | -110.29% | -109.96% | -165.47% | -167.26% | 239.64% |
| Income Before Tax | 42.89% | 38.35% | -2,425.97% | -2,495.21% | -43.93% |
| Income Tax Expenses | 228.12% | 224.04% | -38.16% | -41.95% | -368.20% |
| Earnings from Continuing Operations | -49.02% | -50.65% | -377.17% | -384.77% | -4.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.02% | -50.65% | -377.17% | -384.77% | -4.95% |
| EBIT | -110.29% | -109.96% | -165.47% | -167.26% | 239.64% |
| EBITDA | -45.39% | -47.12% | -93.18% | -69.12% | 468.00% |
| EPS Basic | -48.97% | -50.65% | -314.85% | -320.72% | -30.90% |
| Normalized Basic EPS | -1,113.33% | -1,025.00% | 73.24% | 72.59% | 88.28% |
| EPS Diluted | -49.45% | -51.01% | -314.85% | -320.72% | -30.90% |
| Normalized Diluted EPS | -1,113.33% | -1,025.00% | 73.24% | 72.59% | 88.28% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 29.10% | 29.10% | 37.53% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 29.10% | 29.10% | 37.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
